Charles RPh - Wellgistics Health Chief Officer
| WGRX Stock | 0.41 0 0.98% |
Executive
Charles RPh is Chief Officer of Wellgistics Health Common
| Age | 62 |
| Address | 3000 Bayport Drive, Tampa, FL, United States, 33607 |
| Phone | 844 203 6092 |
| Web | https://www.wellgisticshealth.com |
Wellgistics Health Management Efficiency
The company has return on total asset (ROA) of (0.8323) % which means that it has lost $0.8323 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (9.2767) %, meaning that it created substantial loss on money invested by shareholders. Wellgistics Health's management efficiency ratios could be used to measure how well Wellgistics Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.35 in 2026. Return On Capital Employed is likely to rise to -0.35 in 2026. At this time, Wellgistics Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 50.9 M in 2026, whereas Non Currrent Assets Other are likely to drop slightly above 1.3 M in 2026.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Richa Gujarati | Heartbeam | N/A | |
| Daniel Carlson | INmune Bio | 59 | |
| Kevin Brennan | Xilio Development | 56 | |
| MD FCCP | Biodesix | N/A | |
| James Blake | OnKure Therapeutics | N/A | |
| Gael MBA | Volitionrx | 45 | |
| Cory Ellspermann | INmune Bio | N/A | |
| Rogan Nunn | OnKure Therapeutics | N/A | |
| Steven Springmeyer | Biodesix | N/A | |
| Joshua Esq | INmune Bio | N/A | |
| Ruth Moulin | Xilio Development | N/A | |
| Mark Schiller | Kezar Life Sciences | 46 | |
| Pattie Chiang | Kezar Life Sciences | 63 | |
| Jacob Micallef | Volitionrx | 68 | |
| Katarina MD | Xilio Development | 50 | |
| Kevin Litwiler | OnKure Therapeutics | N/A | |
| Louisa Smith | Tela Bio | N/A | |
| Kristina MBA | Aligos Therapeutics | N/A | |
| David Smith | Aligos Therapeutics | N/A | |
| Jacob MBA | Volitionrx | 70 | |
| Kieron Wesson | Aligos Therapeutics | N/A | |
Management Performance
| Return On Equity | -9.28 | ||||
| Return On Asset | -0.83 |
Wellgistics Health Common Leadership Team
Elected by the shareholders, the Wellgistics Health's board of directors comprises two types of representatives: Wellgistics Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wellgistics. The board's role is to monitor Wellgistics Health's management team and ensure that shareholders' interests are well served. Wellgistics Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wellgistics Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brett Thompson, CTO Technology | ||
| Doug Esq, Director Compliance | ||
| Brett Bryant, Executive Operations | ||
| Shafaat PharmD, Chief Operations | ||
| Jason Lang, President Distribution | ||
| RPh MSc, President InterimCEO | ||
| Charles RPh, Chief Officer | ||
| Tony Madsen, Chief Officer | ||
| David Madsen, Chief Officer | ||
| Srini Kalla, Chief Officer | ||
| RPh BCNP, Chief Officer | ||
| Prashant RPh, Chief Board | ||
| Ari Aichbhaumik, Senior Chain | ||
| Timothy Canning, Chief Officer | ||
| Brian Norton, Chief Distribution | ||
| Vishnu Balu, VP CFO | ||
| Srinivas Kalla, Chief Officer | ||
| Nikul Panchal, President Operations | ||
| Eric CPA, InterimCFO | ||
| Shelley Bailey, Chief Officer |
Wellgistics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Wellgistics Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -9.28 | ||||
| Return On Asset | -0.83 | ||||
| Profit Margin | (2.28) % | ||||
| Operating Margin | (10.47) % | ||||
| Current Valuation | 63.47 M | ||||
| Shares Outstanding | 102.12 M | ||||
| Shares Owned By Insiders | 56.78 % | ||||
| Shares Owned By Institutions | 4.78 % | ||||
| Number Of Shares Shorted | 695.22 K | ||||
| Price To Book | 6.12 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Wellgistics Stock Analysis
When running Wellgistics Health's price analysis, check to measure Wellgistics Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wellgistics Health is operating at the current time. Most of Wellgistics Health's value examination focuses on studying past and present price action to predict the probability of Wellgistics Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wellgistics Health's price. Additionally, you may evaluate how the addition of Wellgistics Health to your portfolios can decrease your overall portfolio volatility.